Urinary profiling of benign prostate hyperplasia by UPLC-FTMS and UPLC-ion trap MS/MS.

机译：UPLC-FTMS和UPLC离子阱MS / MS对良性前列腺增生的泌尿剖析。

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

1. UPLC-FTMS and UPLC-ion trap MS/MS are a stable and accurate platform for urinary metabolomic analysis. 2. Ion trap can help in the metabolite identification when no authentic standard is available.

机译：UPLC-FTMS和UPLC离子阱MS / MS是尿代谢分析的稳定和准确的平台。 2.无需正品标准，离子捕集器可以帮助代谢物识别。

著录项

来源
《American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics》|2012年||共1页
会议地点
作者
Yi-Ting Kao; Shih-Ying Chen; Yi-Ting Chen; Chien-Lun Chen; Chiun-Gung Juo;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类 TB994.5-53;
关键词

相似文献

外文文献
中文文献
专利

1. Determination of Multiple Pesticide Residues in Okra by QuEChERS Combined with PTV-GC-MS/MS and UPLC-MS/MS [J] . Jingwen FU, Yuchan LIN, Zijing HUANG, 药用植物：英文版 . 2018,第003期
2. Sensitivity to change of the USP score (Urinary Symptoms Profile) after surgical treatment of benign prostatic hyperplasia (BPH) [Sensibilité au changement du score USP (Urinary Symptoms Profile) après traitement chirurgical de l'hypertrophie bénigne de la prostate (HBP)] [J] . WakrimB., AristideKaboréF., SebbaniM., Progres en urologie: journal de l’Association francaise d’urologie et de la Societefrancaise d’urologie . 2014,第4期

机译：良性前列腺增生症（BPH）手术治疗后USP评分（尿路症状档案）的变化敏感性[BPH]外科治疗良性前列腺增生（BPH）手术后USP评分（尿路症状档案）的变化敏感性]
3. Antimicrobial Resistance Profile of Urinary Isolates from Patients with Indwelling Urinary Catheter Diagnosed of Benign Prostate Hyperplasia in Bida, Niger State, Nigeria [J] . British Journal of Pharmaceutical Research . 2016,第3期

机译：尼日利亚尼日尔州比达市的尿道留置导管患者的尿液分离物的耐药性诊断为良性前列腺增生
4. Comparative efficacy and safety profile of 4 vs 8?mg of silodosin once daily usage in patients with benign prostatic hyperplasia–related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity [J] . Abdullah Gul, Soner Coban, Ali Riza Turkoglu, Prostate International . 2020,第4期

机译：比较疗效和安全性曲线为4毫克硅霉素均每日使用良性前列腺增生患者患者与国际前列腺症状评分严重程度分为亚组
5. Urinary profiling of benign prostate hyperplasia by UPLC-FTMS and UPLC-ion trap MS/MS. [C] . Yi-Ting Kao, Shih-Ying Chen, Yi-Ting Chen, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：UPLC-FTMS和UPLC离子阱MS / MS对良性前列腺增生的泌尿剖析。
6. The Feasibility of Fourier Transform Infrared Imaging Spectroscopy in Discriminating Benign Prostatic Hyperplasia From Prostate Cancer in Blood Serum Samples [D] . Monjardez, Geraldine. 2013

机译：傅里叶变换红外成像光谱技术从血清样品中区分前列腺癌与前列腺癌的可行性
7. Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study [O] . Amr S. El-Dakhakhny, Tarek Gharib, Ahmed Issam, 2019

机译：会阴前列腺内注射肉毒杆菌神经毒素A与经尿道前列腺切除术治疗良性前列腺增生继发的下尿路症状：一项前瞻性随机研究
8. Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study [O] . Amr S. El-Dakhakhny, Tarek Gharib, Ahmed Issam, 2019

机译：细胞体内脑内注射肉毒杆菌神经毒素A与经尿道切除前列腺前列腺治疗患者症状中学患者：一项潜在的随机研究

Urinary profiling of benign prostate hyperplasia by UPLC-FTMS and UPLC-ion trap MS/MS.

摘要

著录项

相似文献

相关主题

期刊订阅